Gospodinov D, Hadzhiilieva L, Gerasimov N. Incretin axis in cardiometabolic disease: molecular and systemic mechanisms of GLP-1 and GIP therapies. MR [Internet]. 2026 Sep. 3 [cited 2026 Sep. 14];62(5):5-11. Available from: https://journals.mu-sofia.bg/index.php/mr/article/view/1128